bpc-157+tb-500 blend BPC-157/TB-500 BPC-157 + TB-500 Blend Peptide

Bismuth Oxide and Bismuth Subgallate are mild astringents and antiseptics that protect mucous membranes and raw surfaces

Australia On 19 June 2026, the Therapeutic Goods Administration and Australia's Chief Medical Officer named BPC-157 among unapproved peptide products of public-health concern

We advise against use in patients with active cancer, cardiovascular disease, autoimmune disorders, liver or kidney disease, clotting issues, pregnancy or breastfeeding, or those under age 20

Also, it is important to rule out other causes of pain at the inner aspect of the elbow, like cubital tunnel syndrome and pressure upon the ulnar nerve